The largest database of trusted experimental protocols

6 protocols using crl 9855

1

Cell Culture Protocols for Diverse Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human liver cell line (THLE-3), cancer cell lines (SNU-475 and SNU-423), normal B lymphocyte (CCL-156) and normal monocyte/macrophage (CRL-9855) were purchased from American Type Culture Collection (ATCC, Manassas, Virginia, USA). SNU-475, SNU-423 and CCL-156 were cultured in Roswell Park Memorial Institute medium (RPMI-1640) supplemented with 10% heat inactivated fetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO) and 1% penicillin and streptomycin. THLE-3 was grown in Bronchial Epithelial Cell Growth Medium (BGEM) bulletkitTM (Lonza/Clonetics Corporation, Walksrsville, MD 21793) whereas, CRL-9855 was grown in Iscove’s Modified Dulbecco’s Medium (IMDM, ATCC 30-2005, Manassas, Virginia, USA) with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate and supplemented with 0.05 mM 2-mercaptoethanol, 0.1 mM hypoxanthine and 0.016 mM thymidine, 90%; fetal bovine serum, 10%. All cell lines were cultured in a humidified incubator with 5% CO2 at 37 °C. All experiments were conducted on cell lines with passage number 1 to 10.
+ Open protocol
+ Expand
2

Monocyte-to-Macrophage Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated human monocytes (CRL-9855™) were purchased from ATCC® and sub-cultured in RPMI 1640 (Merck, Darmstadt, Germany) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% sodium pyruvate (all from Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA) at 37 °C and 5% CO2.
For differentiation into macrophages, the monocytes were seeded in 96 multi-well culture plates (0.5 × 104 cells/well) for the MTT assay and in 150 mm cell culture dishes (0.1 × 107 cells/dish) for the immunoblotting and stimulated with 100 ng/mL of PMA (phorbol-12-myristate-13-acetate, purchased from Merck, Darmstadt, Germany, stock solution 1 mM in DMSO) in complete RPMI for 48 h at 37 °C and 5% CO2. After 48 h, a culture of macrophage-like cells was obtained and used for further experimental procedures.
+ Open protocol
+ Expand
3

Human Monocyte and Dental Pulp Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocytes (CRL-9855™) were purchased from ATCC® and sub-cultured in RPMI 1640 (EuroClone, Milan, Italy) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% sodium pyruvate (all from Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA) at 37 °C and 5% CO2.
Primary human dental pulp cells (HDPCs) were obtained as previously reported [33 (link)]. According to the Italian Legislation and the code of ethical principles for medical research involving human subjects of the World Medical Association (Declaration of Helsinki), young donors who underwent extraction of the third molar signed an informed consent form. This project has received the approval of the Local Ethical Committee of the University of Chieti-Pescara (approval number 1173, date of approval 31 March 2016). HPCs were maintained in MEM alpha (EuroClone, Milan, Italy) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 1% penicillin/streptomycin (all from Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA).
+ Open protocol
+ Expand
4

Cell Culture and Treatment Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
THP1 cells were cultured in RPMI1460 media supplemented with 10% fetal bovine serum (FBS), 2 mM L-Glutamine, 100 μg/mL streptomycin and 100 U/ml penicillin at 37°C in 5% CO2. MCF7, BT549 cells were grown in DMEM supplemented with 10% fetal bovine serum (FBS), 2 mM L-Glutamine, 100 μg/mL streptomycin and 100 U/ml penicillin at 37°C in 5% CO2. Cells were treated with indicated concentrations of therapies for indicated periods of time. All cell lines and monocytes (CRL9855) were obtained from ATCC (Sykes et al., 2016 (link)). Cell lines were tested for Mycoplasma (Promega) and authenticated by the ATCC Cell Authentication Testing Service (Lee et al., 2020 (link)).
+ Open protocol
+ Expand
5

Monocyte to Macrophage Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated human monocytes (CRL-9855™) were purchased from ATCC® and sub-cultured in RPMI 1640 (Merck, Darmstadt, Germany) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% sodium pyruvate (all from Gibco, Invitrogen, Life Technologies, Carlsbad, CA, USA) at 37 °C and 5% CO2. Differentiated macrophages were obtained as previously described26 (link). Both the cell types were seeded at 0.5 × 105 cells/well in multi-well culture plates (Corning, Falcon®, Glendale, Arizona, USA). To establish an inflamed environment, cells were stimulated with LPS 0.5 µg/mL (lipopolysaccharide from Escherichia coli, purchased from Merck, Darmstadt, Germany, stock solution 1 mg/mL in water). Untreated and LPS-stimulated samples were harvested immediately after treatment (T0 = time zero) and after 3 and 24 h and used for further procedures.
+ Open protocol
+ Expand
6

Differentiation and Characterization of SC Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SC cell is a non-cancerous human monocytic cell line that can be differentiated into resting macrophages (SC-macrophages, SCM) [36] (link). To prepare SCM, 2 × 105 SC cells (CRL-9855, ATCC, Virginia, USA) per well were plated in 6-well plates and cultured with complete RPMI supplemented with 10% FBS at 37 °C, 5% CO2. SC cells were exposed to 200 nM phorbol-12-myristate-13-acetate (PMA, Sigma-Aldrich) for 3 d to allow monocytic differentiation, followed by the removal of PMA and continued 5-day culture to obtain resting SCM.
Flow cytometry (FCM) was performed to measure the CD14 expression on SC cells and SCM. Cells were washed twice with PBS, and treated with Human Trustain FcX (BioLegend, Beijing, China) for 15 min to block the Fc receptors. Cells were then stained with FITC conjugated anti-human CD14 antibody or anti-mouse IgG isotype control antibody (Biolegend) for 20 min in dark. For phagocytosis analysis, cells were treated with 2 mL 0.5 µm FluoSpheres carboxylate-modified microspheres (505/515, 1.68 × 108 particles/mL, Thermo). After PBS washes, cells were resuspended and filtered by 70 µm sieve meshes. A FACSCelesta™ Cell Analyzer (BD Biosciences, Shanghai, China) was used for all FCM analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!